Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant neisseria gonorrhoeae infection in south africa and association with cefixime treatment failure

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 6, 2013, Pages 1267-1270

  Lewis, David A ^a,b,c   Sriruttan, Charlotte ^d   Müller, Etienne E ^a   Golparian, Daniel ^e   Gumede, Lindy ^a   Fick, Donald ^f   de Wet, Johan ^g   Maseko, Venessa ^a   Coetzee, Jennifer ^d   Unemo, Magnus ^e  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

^d Ampath National Laboratory Services   (South Africa)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f Meldene Medicross Clinic   (South Africa)

^g Springs Medicross Clinic   (South Africa)

Author keywords

Cefpodoxime; Ceftriaxone; Gonorrhoea; Mosaic penA genes

Indexed keywords

AZITHROMYCIN; CEFIXIME; CEFTRIAXONE; CIPROFLOXACIN; GENTAMICIN; PENICILLIN DERIVATIVE; SPECTINOMYCIN; TETRACYCLINE;

ADULT; AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; DRUG TREATMENT FAILURE; EXTENDED SPECTRUM CEPHALOSPORIN RESISTANCE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SCREENING; GENETIC TRAIT; GONORRHEA; HUMAN; MALE; MEN WHO HAVE SEX WITH MEN; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; ORAL SEX; PHENOTYPE; PROMOTER REGION; SEXUAL BEHAVIOR; SINGLE DRUG DOSE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA; URETHRAL DISCHARGE;

CEFPODOXIME; CEFTRIAXONE; GONORRHOEA; MOSAIC PENA GENES;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CEFIXIME; CEFTIZOXIME; CEPHALOSPORIN RESISTANCE; DNA, BACTERIAL; GENES, BACTERIAL; GONORRHEA; HOMOSEXUALITY, MALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; PHENOTYPE; POLYMERASE CHAIN REACTION; SOUTH AFRICA; TREATMENT FAILURE; UNSAFE SEX;

EID: 84884922548     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt034     Document Type: Article

References (32)

1. Lewis DA. The gonococcus fights back: is this time a knock out. Sex Transm Infect 2010; 86: 415-21.
2. Unemo M, Nicholas RA. Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhoea. Future Microbiol 2012; 7: 1401-22.
3. Tapsall JW, Ndowa F, Lewis DA et al. Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009; 7: 821-34.
4. Hess D, Wu A, Golparian D et al. Genome sequencing of a Neisseria gonorrhoeae isolate of a successful international clone with decreased susceptibility and resistance to extended-spectrum cephalosporins. Antimicrob Agents Chemother 2012; 56: 5633-41.
5. Chisholm SA, Alexander S, Desouza-Thomas L et al. Emergence of a Neisseria gonorrhoeae clone showing decreased susceptibility to cefixime in England and Wales. J Antimicrob Chemother 2011; 66: 2509-12.
6. Unemo M, Golparian D, Nicholas R et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012; 56: 1273-80.
7. Whiley DM, Limnios EA, Ray S et al. Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 2007; 51: 3111-6.
8. Lindberg R, Fredlund H, Nicholas R et al. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 2007; 51: 2117-22.
9. Zhao S, Duncan M, Tomberg J et al. Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 2009; 53: 3744-51.
10. Gill MJ, Simjee S, Al-Hattawi K et al. Gonococcal resistance to b-lactams and tetracycline involves mutation in loop 3 of the porin encoded at the penB locus. Antimicrob Agents Chemother 1998; 42: 2799-803.
11. Whiley DM, Jacobsson S, Tapsall JW et al. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains. J Antimicrob Chemother 2010; 65: 2543-7.
12. Lewis DA. Antimicrobial-resistant gonorrhoea in Africa: an important public health threat in need of a regional gonococcal antimicrobial surveillance programme. S Afr J Epid Infect 2011; 26: 215-20.
13. Republic of Namibia Ministry of Health and Social Services. Guidelines for the Management of Sexually Transmitted Infections Using the Syndromic Approach. Windhoek, Namibia: Ministry of Health and Social Services, 2009.
14. National Department of Health. First Line Comprehensive Management and Control of Sexually Transmitted Infections (STIs): Protocol for the Management of a Person With a Sexually Transmitted Infection According to the Essential Drug List. Pretoria, South Africa: National Department of Health, 2008.
15. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-second Informational Supplement M100-S22. CLSI, Wayne, PA, USA, 2012.
16. Unemo M, Fasth O, Fredlund H et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. J Antimicrob Chemother 2009; 63: 1142-51.
17. EUCAST. Breakpoint Tables for Interpretation of MICs and Zone Diameters, Version 1.3, January 5 2011. http://www.eucast.org/ fileadmin/src/media/PDFs/EUCAST_files/Disk_test_documents/EUCAST_ breakpoints_v1.3_pdf.pdf (6 December 2012, date last accessed).
18. Daly CC, Hoffman I, Hobbs M et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol 1997; 35: 2985-8.
19. Whiley D, Bates J, Limnios A et al. Use of a novel screening PCR indicates presence of Neisseria gonorrhoeae isolates with a mosaic penA gene sequence in Australia. Pathology 2007; 39: 445-6.
20. Martin IM, Ison CA, Aanensen DM et al. Rapid sequence-based identification of gonococcal transmission clusters in a large metropolitan area. J Infect Dis 2004; 189: 1497-505.
21. Jolley KA. Multi-locus sequence typing. In: Pollard AJ, Maiden MC, eds. Meningococcal Disease: Methods and Protocols. Totowa, NJ: Humana Press, 2001; 173-86.
22. Ohnishi M, Watanabe Y, Ono E et al. Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 2010; 54: 1060-7.
23. Jolley KA, Chan MS, Maiden MC. mlstdbNet - distributed multi-locus sequence typing (MLST) databases. BMC Bioinformatics 2004; 5: 86.
24. Pandori M, Barry PM, Wu A et al. Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 2009; 53: 4032-4.
25. Ohnishi M, Golparian D, Shimuta K et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011; 55: 3538-45.
26. Allen VG, Mitterni L, Seah C et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. JAMA 2013; 309: 163-70.
27. Camara J, Serra J, Ayats J et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012; 67: 1858-60.
28. Unemo M, Golparian D, Potocnik M et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011. Euro Surveill 2012; 17: 1/4;20200.
29. CDC. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011; 60: 873-7.
30. Moran JS. Treating uncomplicated Neisseria gonorrhoeae infections: is the anatomic site of infection important? Sex Transm Dis 1995; 22: 39-47.
31. Barry PM, Klausner JD. The use of cephalosporins for gonorrhea: the impending problem of resistance. Expert Opin Pharmacother 2009; 10: 555-77.
32. WHO. Global Action Plan to Control the Spread and Impact of Antimicrobial Resistance in Neisseria gonorrhoeae. 2012. http://whqlibdoc. who.int/publications/2012/9789241503501_eng.pdf (6 December 2012, date last accessed).